子宫肌瘤

方法选择子宫肌瘤病人60例，随机分为CSEA组（30例）和EA组（3O例）。

Methods 60 patients with myoma of uterus undergoing vaginal total hysterectomy were selected . They were randomly divided into CSEA group ( 30 cases ) and EA group ( 30 cases ) .

方法：May-Gr櫣nwald-Giemsa染色法对35例子宫肌瘤患者外周血大颗粒淋巴细胞（LGL）数量变化进行观察。

Methods : We investigated the number of the peripheral blood large granular lymphocytes ( LGL ) in 35 patients with myoma of uterus by using the May-Gr ü nwald-Giemsa staining .

卵巢卵泡膜细胞瘤、纤维瘤与浆膜下子宫肌瘤的MR影像研究

MR Study of Ovarian Thecoma , Fibroma and Subserosal Leiomyoma

动态增强CT扫描对子宫肌瘤的诊断价值

The diagnostic value of dynamic enhanced CT scan to uterine leiomyomas

巨大子宫肌瘤的CT诊断

CT Diagnosis of Giant Hysteromyoma

子宫肌瘤患者血清SOD、MDA的观察

Determination of SOD , MDA in Serum of Patients with Uterine Myoma

目的总结13例不典型子宫肌瘤的CT与超声表现，以期提高其诊断与鉴别诊断的准确性。

Objective To summarize atypical CT and Ultrasonography ( US ) findings of uterine myoma in 13 cases , to improve its diagnostic accuracy .

PVA颗粒栓塞治疗子宫肌瘤的临床疗效观察

The clinical efficiency of uterine artery embolization with PVA for the treatment of uterine myoma

子宫肌瘤组，对照组与正常组外周静脉血的E2浓度差异无统计学意义。

No statistical difference was found among the E2 concentrations of peripheral venous blood in patients with leiomyoma , endometriosis and healthy women .

结果子宫肌瘤患者与对照组ABO血型分布一致，均为B>O>A>AB，且P均>0.05。

Results ABO blood group distribution of the patients with myoma of uterus and that of the control group were alike .

目的研究子宫肌瘤患者雌激素受体（ER）的改变及其性激素调节。

Objective To study the changes of estrogen receptor ( ER ) in patients with uterine myoma and its sex hormone regulation .

UAE和子宫肌瘤手术对卵巢功能影响的研究

Effects of UAE and uterine fibroid surgery on ovarian function

经秩和检验，P0.05，不能认为两组在缩小子宫肌瘤疗效方面不同，说明两组治疗子宫肌瘤都有一定的疗效。

The Rank test showed no differences in curative effect in treating uterine fibroids , which demonstrated that both two groups have certain curative effect .

基于NBC的子宫肌瘤辅助诊断方法

Assisted Diagnosis for Uterine Myoma Based on NBC

子宫肌瘤中IGF-1受体的变化及其与雌、孕激素受体、PCNA和Bcl-2的关系

Changes of IGF-1 receptors in uterine leiomyoma and its correlation with estrogen receptor , progesterone receptor , pcna and Bcl-2

目前HIFU技术已应用于临床治疗子宫肌瘤，且疗效肯定。

Thus , HIFU technology has been effectively applied to the current clinical treatment of uterine leiomyomas .

采用实时荧光定量PCR、westernblot及荧光免疫组织化学方法探查FBN-1mRNA和蛋白在体外培养的子宫肌瘤平滑肌细胞中的表达。

FBN-1 mRNA and protein expressions in LSMC and myometrium smooth muscle cells ( MSMC ) were examined by quantitative real time PCR , Western blot and Immunofluorescence staining .

目的：探讨UAE治疗子宫肌瘤的临床效果。

Objective : To discuss the clinical value and effectivity by using UAE in treating hysteromyoma .

目的：研究bcl-2蛋白和增殖细胞核抗原（PCNA）在子宫肌瘤和正常子宫肌层中的表达及其在肌瘤发生发展中的作用。

Objective : To study the expression of bcl-2 protein and proliferating cell nuclear antigen ( PCNA ) in uterine leiomyomas and in normal myometrium .

Bcl-2在子宫肌瘤中的高表达和Caspase-3的低表达提示子宫肌瘤细胞的凋亡被抑制，细胞寿命延长，此可能是子宫肌瘤发生的机制之一；

The higher expression of Bcl-2 and lower expression of caspase-3 demonstrate that the apoptosis of leiomyoma cells was resisted , the cells'life was prolonged .

目的评估采用腹腔镜辅助下腹壁小切口行肌壁间子宫肌瘤切除术（LAM）的可行性和安全性。

Objective To evaluate the feasibility and safety of laparoscopically assisted myomectomy ( LAM ) for uterine intramural fibroids .

症状性子宫肌瘤子宫内膜中PGI2、TXA2、NOS的表达

Expression levels of PGI_2 , TXA_2 and NOS in the endometrium of patients with symptomatic uterine leiomyomas

【结果】ET-1和ETA在子宫肌瘤组织和正常子宫肌组织中均有程度不同的表达。

【 Results 】① There were certain extent expression of ET-1 and ETA in the uterine leiomyoma and the normal myometrium .

GnRH-a对子宫肌瘤自身芳香酶产生的抑制作用

Inhibition of expression of aromatase P450 in leiomyoma of the uterus by GnRH-a

ET-1在子宫肌瘤组织中的阳性表达占83.3%，正常子宫肌组织中的阳性表达为73.3%，两者相比差异无显著性（P>0.05）。

There was no difference for positive expression of ET-1 between the uterine leiomyoma ( 83.3 % ) and the normal myometrium ( 73.3 % ) .

方法36例子宫肌瘤患者，随机分为3组，采用与碘油不同栓塞剂组合，行双侧子宫动脉栓塞（UAE）治疗。

Methods 36 cases of hysteromyoma were divided randomly into 3 groups and treated with uterine artery embolization ( UAE ) .

1例浆膜下、多发子宫肌瘤（小于2cm）穿孔。

One patient with multiple subserous myomas ( less than 2 cm ) was perforated .

p53蛋白表达阳性率在不同年龄、是否绝经、是否伴有子宫肌瘤、肿瘤部位、组织类型、分化程度、有无淋巴结转移、Dukes'分期间的差异无显著性（P＞0.05）。

There was no significant differences between the expression of Mutant p53 protein and patient age , menopausal statu , hysteromyoma , tumor location , histological type , histological differentiation , lymph nodal metastases , Dukes ' stage .

子宫肌瘤的ER、PR与血浆的E＿2、P含量无明显相关性，而与LH、FSH含量呈负相关（P＜0.05）；

ER , PR contents of leiomyoma did not correlate with serum E_02 and P concentrations , but correlate negatively with serum LH and FSH levels ( P < 0 . 05 0 ) .

结果：子宫肌瘤患者无论增殖期或是分泌期血中E2、P、PRL均显著高于对照组（P<0.05）；

Results : Serum E2 , P and PRL level of patients with hysteromyoma in the proliferation period or secretion period were higher than that of control group ( P < 0.05 );